Purpose: We developed a standardized critical pathway for gastric cancer surgery and then determined the increase of application, which resulted in an improvement in terms of measurable indices, such as hospital stay and cost. Materials and Methods: A critical pathway was revised and used widely from the 2nd quarter of 2009. We collected clinical data, such as length of stay and complication rate, as clinical indices of quality prospectively. The total cost paid at the patient's discharge, as well as the daily hospital income, were calculated and compared by each quarter from January 2008 to December 2009. Results: The application rate of critical pathway was 11.8% and 87.8% in 2008 and 2009, respectively. There were no perioperative deaths. There was no difference in the complication rates between 2008 and 2009 (P=0.45). However, the mean length of stay was significantly different between the 2 years (P<0.05). Although the total cost was not different, the daily hospital income was significantly higher in the latter year (P<0.05). Conclusions: An increase in the application of critical pathway for gastrectomy resulted in significant decreases in length of stay and increases in the daily hospital income without a compromise on the clinical indices.
Introduction
Gastric cancer is the most common cancer in Korea, accounting for more than 25,000 new cases per year, and the second most common cause of cancer-related deaths. Although the incidence has decreased gradually and the proportion of early-stage cases has increased to 40~50%,(1) gastric cancer presents a notable burden to health payers in Korea.
The critical pathway (CP) is a standardized measure that is planned on a time-based schedule for patient management. The use of CP has been proposed as a way of improving health care processes, outcomes, and costs. (2, 3) In the surgical setting, each step of treatment can be standardized using CP, which can prevent unnecessary or ineffective procedures. Therefore, we can expect a reduction in inappropriate care, an increased clinical efficiency, better control of health care spending, and a higher level of patient satisfaction.
For these reasons, there has been an increasing worldwide interest over the last 2 decades in CP development and implementation. (4) (5) (6) (7) Despite the growing utilization of these pathways in medicine, the effect of a CP for gastrectomy has not been fully investigated.
In this study, we developed a "CP of Operable Gastric Cancer" and examined the effect of increased application rate of this CP for gastrectomy in terms of cost and length of hospital stay in patients with gastric cancer.
Materials and Methods

Development and revision
We developed a standardized CP for gastric cancer patients (Fig.   1 ). At the same time, the house staff tried to set up a CP protocol on a daily basis at the patients' initial visits to our out-patient clinic.
With the effort to minimize the evaluation period pre-operatively and train our in-patient care nursing staff who routinely worked with and educated the patients, the CP application rate has increased to 87.8%.
Elements of the CP
In 2009, as part of our revision, we separated the CP into 2 parts: the out-patient CP (OPCP) and the in-patient CP (IPCP).
All patients with histologically confirmed, resectable, gastric adenocarcinoma were eligible. From a total of 452 patients who underwent curative resection of stomach, 397 patients (87.8%) were included in this CP in 2009. These patients were divided as OPCP (n=290) and IPCP (n=107).
If the patient had no comorbidity or any minor illness, he/ she was enrolled in the OPCP group, underwent all pre-operative workups, and was admitted 1 day before operation. The workup evaluation consisted of the patient's history, physical examination, laboratory tests including tumor markers (carcinoembrionic antigen and CA 19-9), chest radiography, endoscopy, 3-dimensional computed tomography (CT), and bone scintigraphy. If the patient had a major illness, severe malnutrition, or severe anemia, the pre-operative workup and build-up proceeded simultaneously after admission. These patients were enrolled in the IPCP group, which started at 1 day before operation. The routine process from 1 day before operation was the same in both CPs. No nasogastric tube was used and no bowel preparation was performed before surgery. We made a pathway brochure, which explained the anticipated sequence of events in lay terms for the patients and their family. This brochure was broken into the following categories: diet, activity, procedures, medication, laboratory tests, and education ( Table 1 ). The patients started taking small sips of water on post-operative day 3 and solid meals on post-operative day 5. On post-operative day 4 and the day of discharge (post-operative day, POD #6), the patients were educated about adequate nutrition. They also received a detailed instruction sheet upon discharge that outlined their recommended 
Patients
Statistical analysis
To compare the continuous variables between the groups, the Mann-Whitney U test was used. The dichotomous variables were compared using the chi-square test or, when appropriate, Fisher's exact test. The results are expressed as mean (standard deviation) unless otherwise stated. A P-value of less than 0.05 was considered to indicate statistical significance.
Results
The clinicopathological characteristics are shown in Table 2 .
Gastrectomy was performed in 242 and 452 patients in 2008 and (Fig. 3) .
Discussion
It is possible to develop and apply CP to gastric cancer patients.
The application of CP to daily clinical practices could also decrease the duration of hospital stay and increase the daily hospital income per practice. In addition, the maintenance of high qualities of CP would depend upon systemic support, such as the hiring of health professionals for CP and the setting-up of an institution-wide support system. Most importantly, mutual understanding and coopera- tion between the CP team is mandatory for a successful CP.
The pre-operative preparation process was the key barrier to applying CP to gastrectomy patients, whereas the post-operative hospital stays were not significantly different between the CP-applied and non-CP-applied patients. To minimize the total hospital stays, there was a need to reduce the pre-operative hospital stays.
We performed pre-operative evaluation studies, such as duodenoscopy, CT, positron emission tomography, and blood panels, on clinic-based out-patients as a "One-stop" system. We also refrained from inserting the Levin tube pre-operatively and skipped the pre-operative bowel preparation process. These simplifications of pre-operative preparation set admission at 1 day before surgery. This study demonstrates that it is possible to develop and apply CP to gastric cancer patients and CP can impact on hospital stay and costs, while patients' safety remains unaffected. But the most important thing to remind is that the maintenance of high qualities of CP would depend upon an institution-wide support system.
Moreover, mutual understanding and co-operation between the CP team is mandatory for a successful CP.
